We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-10.61%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$845M
AUM Growth
-$125M
Cap. Flow
-$13.7M
Cap. Flow %
-1.62%
Top 10 Hldgs %
30.78%
Holding
184
New
1
Increased
38
Reduced
77
Closed
19

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$18.4M
2
CB icon
Chubb
CB
+$2.56M
3
RTX icon
RTX Corp
RTX
+$1.98M
4
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$1.84M
5
TRMB icon
Trimble
TRMB
+$1.38M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$19.1M
2
COL
Rockwell Collins
COL
+$8.66M
3
WPP icon
WPP
WPP
+$7.11M
4
T icon
AT&T
T
+$2.18M
5
XRAY icon
Dentsply Sirona
XRAY
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 18.38%
3 Financials 12.05%
4 Consumer Staples 11.36%
5 Industrials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
101
Ionis Pharmaceuticals
IONS
$8.93B
$743K 0.09%
13,744
+165
+1% +$8.41K
ISRG icon
102
Intuitive Surgical
ISRG
$127B
$740K 0.09%
4,638
PM icon
103
Philip Morris
PM
$309B
$705K 0.08%
10,561
-1,648
-13% -$138K
GLD icon
104
SPDR Gold Trust
GLD
$131B
$694K 0.08%
5,727
KHC icon
105
Kraft Heinz
KHC
$32.8B
$688K 0.08%
15,989
-1,768
-10% -$91.6K
SCHW
106
Charles Schwab
SCHW
$182B
$668K 0.08%
16,092
RDS.A
107
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$646K 0.08%
11,078
-61
-0.5% -$3.78K
SGEN
108
DELISTED
Seagen Inc. Common Stock
SGEN
$641K 0.08%
11,315
+144
+1% +$9.03K
VV icon
109
Vanguard Large-Cap ETF
VV
$51.2B
$630K 0.07%
5,485
V icon
110
Visa
V
$701B
$625K 0.07%
4,740
-50
-1% -$6.91K
VEU icon
111
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$582K 0.07%
12,770
+1,770
+16% +$85K
BMRN icon
112
BioMarin Pharmaceuticals
BMRN
$11.9B
$575K 0.07%
6,756
+94
+1% +$8.94K
CSX icon
113
CSX Corp
CSX
$94B
$565K 0.07%
27,300
-300
-1% -$6.9K
NBIX icon
114
Neurocrine Biosciences
NBIX
$18.2B
$558K 0.07%
7,820
+65
+0.8% +$6.23K
ABBV icon
115
AbbVie
ABBV
$465B
$534K 0.06%
5,794
-1,167
-17% -$103K
MCD icon
116
McDonald's
MCD
$193B
$533K 0.06%
3,004
MO icon
117
Altria Group
MO
$125B
$522K 0.06%
10,572
-982
-8% -$56.9K
OMC icon
118
Omnicom Group
OMC
$23.5B
$521K 0.06%
7,111
FISV
119
Fiserv Inc
FISV
$29.7B
$518K 0.06%
7,048
INCY icon
120
Incyte
INCY
$25.4B
$517K 0.06%
8,137
+169
+2% +$11K
FUL icon
121
H.B. Fuller
FUL
$3B
$516K 0.06%
12,094
NEE icon
122
NextEra Energy
NEE
$184B
$495K 0.06%
11,380
AMZN icon
123
Amazon
AMZN
$2.44T
$494K 0.06%
6,580
-120
-2% -$9.98K
ED icon
124
Consolidated Edison
ED
$41.4B
$470K 0.06%
6,146
WBA
125
DELISTED
Walgreens Boots Alliance
WBA
$468K 0.06%
6,852

Similar funds

Grandfield & Dodd's Q4 2018 Portfolio in Review

As of Q4 2018, Grandfield & Dodd held 184 positions worth $845M, down 13% from $970M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q4 2018 filing shows 1 new, 38 increased, 77 reduced and 19 closed positions. Its largest new stake was Linde: 116,658 shares worth $18.2M. The largest sale was Praxair Inc, an estimated $19.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q4 2018 buy was Linde: 116,658 shares worth $18.2M.
  • Grandfield & Dodd added most to Chubb in Q4 2018, an estimated $2.56M increase.
  • Grandfield & Dodd's biggest Q4 2018 reduction was WPP, cutting an estimated $7.11M.
  • Grandfield & Dodd fully exited Praxair Inc in Q4 2018, selling an estimated $19.1M.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $845M portfolio in Q4 2018.
  • Grandfield & Dodd opened 1 new position and closed 19 in Q4 2018.
  • Grandfield & Dodd's portfolio value fell 13% quarter-over-quarter to $845M.

Based on Grandfield & Dodd's 13F filing for Q4 2018, filed 12 Feb 2019.